A single-center, open-label, parallel-group, single-period, single-dose study evaluating Pharmacokinetics Effect of ONC201 on Severe Renal Impairment
Latest Information Update: 24 Jan 2025
Price :
$35 *
At a glance
- Drugs Dordaviprone (Primary)
- Indications Renal impairment
- Focus Pharmacokinetics
- 24 Jan 2025 New trial record